Year after year, the John Theurer Cancer Center (JTCC) harnesses the newest technologies and retains world-class oncologists, nurses, and scientists to fulfill its mission of delivering extraordinary care to patients in the community.

Oncology & Biotech News   >   Academy

Pharmaceutical companies are investing billions of dollars and have more than 900 cancer medications in the pipelines.

Oncology Live   >   Cover Story

Hanahan and Weinberg initially outlined 6 hallmarks that they believed were essential to the transformation of normal cells into malignant cancer cells in most, if not all, human cancers.

Oncology Live   >   Pathways

Dr. Yuri Lazebnik's research focuses on how cells become cancerous, how cancer cells evolve, and how they can be killed selectively.

Oncology Live   >   Pathways

It is increasingly recognized that the realm of molecular diagnostic testing in oncology is undergoing as much change, if not more, as the world of cancer therapeutics.

Oncology Live   >   From the Editor

The treatment of Gaucher disease is poised to enter a new era as a result of advances in the understanding of the cellular pathways at work in the disorder.

Conferences   >   Updates From the ICHG/ASHG 61st Annual Meeting